Janux Therapeutics, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Janux Therapeutics, Inc. | JANX - NASDAQ |
$15.00-$17.00 | $17.00 | $34.00 | 11.4 million | 6/11/2021 |
| BofA Securities, Cowen, Evercore ISI | ||||||
Co-Manager(s): HC Wainwright
| ||||||
| Health Care | ||||||
Filing(s): Filed 2021-05-19 Terms Added 2021-06-07 | ||||||
Janux Therapeutics, Inc. Quote & Chart - Click for current quote - JANX
IPO Boutique aggregates information on public companies and private companies, such as "JANX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Janux Therapeutics, Inc. (adapted from Janux Therapeutics, Inc. prospectus):
They are an innovative biopharmaceutical company developing next-generation therapeutics based on our proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to better treat patients suffering from cancer.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are an innovative biopharmaceutical company developing next-generation therapeutics based on our proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to better treat patients suffering from cancer.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "JANX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.